|1|Erratum: Omasa M, Date H, Sozu T, Sato T, Nagai K, Yokoi K, Okamoto T, Ikeda N, Tanaka F, and Maniwa Y, and the Japanese Association for Research on the Thymus. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: The Japanese Association for Research on the Thymus Database Study. Cancer. doi: 10.1002/cncr.29166. (26057775) |2015|
|2|Perplexing histologic classification of thymic epithelial tumor. (25997137)
Shen Q.... Feng Z.
|3|Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: The Japanese Association for Research on the Thymus Database Study. (25565590)
Omasa M.... Maniwa Y.
|4|A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. (24974848)
Petrini I.... Giaccone G.
|5|Expression of RAGE and HMGB1 in thymic epithelial tumors, thymic hyperplasia and regular thymic morphology. (24705787)
Moser B.... Ankersmit H.J.
|6|The presence of extrathoracic metastasis is more prognostic of survival than Masaoka stage (IVa/IVb) in metastatic thymic epithelial tumor: a retrospective cohort study. (24954359)
Shin D.Y.... Heo D.S.
|7|Methylation and expression profiles of MGMT gene in thymic epithelial tumors. (24388682)
Mokhtar M.... Tangoku A.
|8|Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor. (23695010)
Moretto R.... Palmieri G.
|9|STAT3 expression correlates with prognosis of thymic epithelial tumors. (23590999)
Li C.... Zhang R.
|10|Copy number aberrations of genes regulating normal thymus development in thymic epithelial tumors. (23444221)
Petrini I.... Giaccone G.
|11|NUT rearrangement is uncommon in human thymic epithelial tumors. (22425924)
Petrini P.... Giaccone G.
|12|Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems. (22974165)
Ma Y.... Wang J.
|13|Is There a Role of Postoperative Radiation Therapy in Completely Resected Stage I/II Thymic Epithelial Tumor? (23091442)
Oh D.... Han J.
|14|Expression of excision repair cross-complementation group 1, breast cancer susceptibility 1, and I^ III-tubulin in thymic epithelial tumors. (21289518)
Kaira K.... Yamamoto N.
|15|MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinoma. (21253760)
Kaira K.... Yamamoto N.
|16|Expression of proteasome subunit I^5t in thymic epithelial tumors. (21836487)
Yamada Y.... Kasahara M.
|17|Successful diagnosis of a combined thymic epithelial tumor by endobronchial ultrasound-guided transbronchial needle aspiration. (23896935)
Okamoto T.... Inase N.
|18|Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors. (21372220)
Breinig M.... Rieker R.J.
|19|Thymic epithelial tumor with heart metastasis in a horse. (20814442)
Shahriar F.... Moore J.
|20|CD98 expression is associated with the grade of malignancy in thymic epithelial tumors. (20811665)
Kaira K.... Yamamoto N.
|21|Type B3 thymic epithelial tumor in an adolescent detected by immunohistochemical staining for CD5, CD99, and KIT (CD117): a case report. (19901887)
Yoshino N.... Shimizu K.
|22|Computed tomographic findings and prognosis in thymic epithelial tumor patients. (18830115)
Yakushiji S.... Kusumoto M.
|23|Absence of gene mutations in KIT-positive thymic epithelial tumors. (18486988)
Tsuchida M.... Hayashi J.I.
|24|Adjuvant radiotherapy for thymic epithelial tumor: treatment results and prognostic factors. (17762439)
Kundel Y.... Levitt M.L.
|25|Correlation between MMP-2 activation and MT1-MMP mRNA expression in thymic epithelial tumors]. (16608644)
Wang Y.... Wang E.H.
|26|Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors. (16762968)
Suzuki E.... Fujii Y.
|27|Multimodality treatment program in invasive thymic epithelial tumor. (15685027)
Jacot W.... Pujol J.L.
|28|Expression of neurotrophin receptors in surgically resected thymic epithelial tumors. (16125946)
Kim D.J.... Chung K.Y.
|29|Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. (16002927)
Nakagawa K.... Tsuchiya R.
|30|Expression of cyclins D1, D3 and p27 in thymic epithelial tumors. (17670226)
Zisis C.... Bellenis I.
|31|High incidence of thymic epithelial tumors in E2F2 transgenic mice. (14684733)
Scheijen B.... Bernards R.
|32|KI-67 antigen expression predicts survival and correlates with histologic subtype in the WHO classification of thymic epithelial tumors. (15494865)
Comin C.E.... Dini S.
|33|Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors. (14584061)
Sogawa K.... Monden Y.
|34|Expression of matrix metalloproteinases 2 and 7 in tumor cells correlates with the World Health Organization classification subtype and clinical stage of thymic epithelial tumors. (14691910)
Takahashi E.... Eimoto T.
|35|Apoptosis in thymic epithelial tumors. (12234065)
Park S.H.... Ro J.Y.
|36|Thymic epithelial tumors can develop along two different pathogenetic pathways. (11696445)
Zhou R.... Starostik P.
|37|Activation of matrix metalloproteinase-2 is correlated with invasiveness in thymic epithelial tumors. (11276020)
Kondo K.... Monden Y.
|38|Differential expression of NGF receptors in human thymic epithelial tumors. (10483585)
Parrens M.... Merlio J.P.
|39|Correlation between clinical aggressiveness of thymic epithelial tumors and expression of tumor suppressor gene products (p53, p27)]. (10496046)
Fukiwake N.... Sugimachi K.
|40|Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma. (9563781)
Hishima T.... Koike M.
|41|Thymic epithelial tumor progression in an SV40T transgenic mouse model. Cortical thymoma-thymic carcinoma sequence. (9463585)
Lee S.S.... Jang J.J.
|42|p53 alteration, proliferating cell nuclear antigen, and nucleolar organizer regions in thymic epithelial tumors. (9852302)
Oyama T.... Yasumoto K.
|43|Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors. (9346177)
Tateyama H.... Takino H.
|44|Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor. (9371941)
Voltz R.D.... Hohlfeld R.
|45|Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies. (8543314)
Yang W.I.... Harris N.L.
|46|p53 protein expression and p53 mutation in thymic epithelial tumors. (8623777)
|47|Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis. (8669470)
Marx A.... MA1ller-Hermelink H.K.
|48|The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors. (7573670)
Chan J.K.... Pau M.Y.
|49|p53 protein expression and p53 gene mutation in thymic epithelial tumors. An immunohistochemical and DNA sequencing study. (7572785)
Tateyama H.... Masaoka A.
|50|Cytokeratins in normal thymus and thymic epithelial tumors. (7677978)
Fukai I.... Tanamura O.